Domain > investors.immatics.com

More information on this domain is in AlienVault OTX

Whois

Property	Value
Email	it@immatics.com
NameServer	SHADES13.RZONE.DE
Created	2000-07-02 00:00:00
Changed	2015-07-02 00:00:00
Expires	2016-07-02 00:00:00
Registrar	CRONON AG

DNS Resolutions

Date	IP Address
2020-07-30	23.42.158.24 (ClassC)
2021-01-01	104.119.188.219 (ClassC)
2024-11-19	23.44.175.167 (ClassC)

HTTP/1.1 200 OKContent-Language: enContent-Type: text/html; charsetUTF-8ETag: 1731998913Expect-CT: max-age0, report-uri/report-expect-ct-violationFeature-Policy: accelerometer none;ambient-light-sensor none;autoplay self;camera none;encrypted-media none;fullscreen self;geolocation self;gyroscope none;magnetometer none;microphone none;midi none;payment none;picture-in-picture none;speaker self;sync-xhr self;usb none;vibrate none;vr noneFrom-Origin: sameLast-Modified: Tue, 19 Nov 2024 06:48:33 GMTReferrer-Policy: no-referrer-when-downgradeStrict-Transport-Security: max-age31536000X-Age: 1124X-Cache-Hits: 1X-Content-Type-Options: nosniffX-Drupal-Dynamic-Cache: UNCACHEABLEX-Frame-Options: SAMEORIGINX-Request-ID: v-4b86fe64-a642-11ef-86c2-1f24ef6adfe9X-XSS-Protection: 1; modeblockCache-Control: public, max-age0, s-maxage2700Expires: Tue, 19 Nov 2024 07:07:18 GMTDate: Tue, 19 Nov 2024 07:07:18 GMTContent-Length: 34206Connection: keep-alive

!DOCTYPE html>html langen dirltr prefixog: https://ogp.me/ns#>  head>    meta charsetutf-8 />meta namedescription contentThe Investor Relations website contains information about Immatics N.V.'s business for stockholders, potential investors, and financial analysts. />link relcanonical hrefhttps://investors.immatics.com/investors-media/ />link relshortlink hrefhttp://investors.immatics.com/ />meta namereferrer contentno-referrer />meta propertyog:site_name contentImmatics N.V. />meta propertyog:type contentwebsite />meta propertyog:url contenthttps://investors.immatics.com/investors-media />meta propertyog:title contentInvestors & Media | Immatics N.V. />meta propertyog:description contentThe Investor Relations website contains information about Immatics N.V.'s business for stockholders, potential investors, and financial analysts. />meta nameGenerator contentDrupal 10 (https://www.drupal.org) />meta nameMobileOptimized contentwidth />meta nameHandheldFriendly contenttrue />meta nameviewport contentwidthdevice-width, initial-scale1.0 />link relicon href/sites/g/files/knoqqb57156/files/favicon_0.ico typeimage/vnd.microsoft.icon />link relalternate hreflangen hrefhttps://investors.immatics.com/ />link relalternate hreflangde hrefhttps://investors.immatics.com/de />    title>Investors & Media | Immatics N.V./title>    link relstylesheet mediaall href/sites/g/files/knoqqb57156/files/css/css_J-6pq4rk2pXqys05Biha2QLDAW93U9erV_FqmvHcdJs.css?delta0&languageen&themenir_pid3658&includeeJyVkWFKBDEMhS-0Tn-I4n9PIB6gpG1wwrTJ0mbUub2ZVpSRXXAptHmPL5CXMlUfF0ykUn0CtRMyNvdbntiQAnVB7YAPWeLiCgL7ilFKQTafhH2coeoVHhjy1tRXQ_nNB6g34M33WQa7ZqViE4M7ylOzBiwuQBvkXnSGonA7WiqSbYZunindPz48OXnHWinhwYyZkPVuRkg48A8MjRQ9i1K0VV3wpu_3VCHRp8-wyarNHdSV4BfdaV8zcLqpp6ndL6voCNTl2Ln7owf6vJevumVbeO_of2A5RsQfNUGSgBZj5Tj_AzxXSV9ssvMQ />link relstylesheet mediaall href/sites/g/files/knoqqb57156/files/css/css_ORgjmuSY3NyDr8q8PPvDfA5agLjHqwnNWwdHe1cc9lQ.css?delta1&languageen&themenir_pid3658&includeeJyVkWFKBDEMhS-0Tn-I4n9PIB6gpG1wwrTJ0mbUub2ZVpSRXXAptHmPL5CXMlUfF0ykUn0CtRMyNvdbntiQAnVB7YAPWeLiCgL7ilFKQTafhH2coeoVHhjy1tRXQ_nNB6g34M33WQa7ZqViE4M7ylOzBiwuQBvkXnSGonA7WiqSbYZunindPz48OXnHWinhwYyZkPVuRkg48A8MjRQ9i1K0VV3wpu_3VCHRp8-wyarNHdSV4BfdaV8zcLqpp6ndL6voCNTl2Ln7owf6vJevumVbeO_of2A5RsQfNUGSgBZj5Tj_AzxXSV9ssvMQ />link relstylesheet mediaall href//pro.fontawesome.com/releases/v5.12.0/css/all.css />link relstylesheet mediaall href/sites/g/files/knoqqb57156/files/css/css_I2UXx8X18CMNKd85ytQccf0UdPIWTUuaJejC94kwPbc.css?delta3&languageen&themenir_pid3658&includeeJyVkWFKBDEMhS-0Tn-I4n9PIB6gpG1wwrTJ0mbUub2ZVpSRXXAptHmPL5CXMlUfF0ykUn0CtRMyNvdbntiQAnVB7YAPWeLiCgL7ilFKQTafhH2coeoVHhjy1tRXQ_nNB6g34M33WQa7ZqViE4M7ylOzBiwuQBvkXnSGonA7WiqSbYZunindPz48OXnHWinhwYyZkPVuRkg48A8MjRQ9i1K0VV3wpu_3VCHRp8-wyarNHdSV4BfdaV8zcLqpp6ndL6voCNTl2Ln7owf6vJevumVbeO_of2A5RsQfNUGSgBZj5Tj_AzxXSV9ssvMQ />link relstylesheet mediaprint href/sites/g/files/knoqqb57156/files/css/css_BcZwsxhJhvEnWYGnfXA0Q_z2oCPSSiosoWLOmfN3vcI.css?delta4&languageen&themenir_pid3658&includeeJyVkWFKBDEMhS-0Tn-I4n9PIB6gpG1wwrTJ0mbUub2ZVpSRXXAptHmPL5CXMlUfF0ykUn0CtRMyNvdbntiQAnVB7YAPWeLiCgL7ilFKQTafhH2coeoVHhjy1tRXQ_nNB6g34M33WQa7ZqViE4M7ylOzBiwuQBvkXnSGonA7WiqSbYZunindPz48OXnHWinhwYyZkPVuRkg48A8MjRQ9i1K0VV3wpu_3VCHRp8-wyarNHdSV4BfdaV8zcLqpp6ndL6voCNTl2Ln7owf6vJevumVbeO_of2A5RsQfNUGSgBZj5Tj_AzxXSV9ssvMQ />link relstylesheet mediaall href/sites/g/files/knoqqb57156/files/css/css_Zr18qEnk_Go2dqdoW6Yj-UfUOK2kdeWsLKdDpi9vA4s.css?delta5&languageen&themenir_pid3658&includeeJyVkWFKBDEMhS-0Tn-I4n9PIB6gpG1wwrTJ0mbUub2ZVpSRXXAptHmPL5CXMlUfF0ykUn0CtRMyNvdbntiQAnVB7YAPWeLiCgL7ilFKQTafhH2coeoVHhjy1tRXQ_nNB6g34M33WQa7ZqViE4M7ylOzBiwuQBvkXnSGonA7WiqSbYZunindPz48OXnHWinhwYyZkPVuRkg48A8MjRQ9i1K0VV3wpu_3VCHRp8-wyarNHdSV4BfdaV8zcLqpp6ndL6voCNTl2Ln7owf6vJevumVbeO_of2A5RsQfNUGSgBZj5Tj_AzxXSV9ssvMQ />link relstylesheet mediaall href//fonts.googleapis.com/css?familyOpen+Sans:300,300italic,regular,italic,600,600italic,700,700italic,800,800italic%7CMontserrat:100,100italic,200,200italic,300,300italic,regular,italic,500,500italic,600,600italic,700,700italic,800,800italic,900,900italic />link relstylesheet mediaall href/sites/g/files/knoqqb57156/files/css/css_T9h-2xzmWLpyjuSC1mQQ-Gt8jbLOqY3I2xKjkoW1nQE.css?delta7&languageen&themenir_pid3658&includeeJyVkWFKBDEMhS-0Tn-I4n9PIB6gpG1wwrTJ0mbUub2ZVpSRXXAptHmPL5CXMlUfF0ykUn0CtRMyNvdbntiQAnVB7YAPWeLiCgL7ilFKQTafhH2coeoVHhjy1tRXQ_nNB6g34M33WQa7ZqViE4M7ylOzBiwuQBvkXnSGonA7WiqSbYZunindPz48OXnHWinhwYyZkPVuRkg48A8MjRQ9i1K0VV3wpu_3VCHRp8-wyarNHdSV4BfdaV8zcLqpp6ndL6voCNTl2Ln7owf6vJevumVbeO_of2A5RsQfNUGSgBZj5Tj_AzxXSV9ssvMQ />    script src/core/assets/vendor/modernizr/modernizr.min.js?v3.11.7>/script>script src/sites/g/files/knoqqb57156/files/js/js_EUp_UuOEEz_TrqGTAB5uyHue-ur9e5VogZTeqJ0xtJI.js?scopeheader&delta1&languageen&themenir_pid3658&includeeJyVkWFKBDEMhS-0Tn-I4n9PIB6gpG1wwrTJ0mbUub2ZVpSRXXAptHmPL5CXMlUfF0ykUn0CtRMyNvdbntiQAnVB7YAPWeLiCgL7ilFKQTafhH2coeoVHhjy1tRXQ_nNB6g34M33WQa7ZqViE4M7ylOzBiwuQBvkXnSGonA7WiqSbYZunindPz48OXnHWinhwYyZkPVuRkg48A8MjRQ9i1K0VV3wpu_3VCHRp8-wyarNHdSV4BfdaV8zcLqpp6ndL6voCNTl2Ln7owf6vJevumVbeO_of2A5RsQfNUGSgBZj5Tj_AzxXSV9ssvMQ>/script>    !-- Matomo -->script typetext/javascript>var _paq  window._paq  window._paq || ;_paq.push(trackPageView);_paq.push(enableLinkTracking);_paq.push(alwaysUseSendBeacon);_paq.push(setTrackerUrl, \/\/immatics.com\/wp-content\/plugins\/matomo\/app\/matomo.php);_paq.push(setSiteId, 1);var ddocument, gd.createElement(script), sd.getElementsByTagName(script)0;g.typetext/javascript;g.asynctrue;g.src\/\/immatics.com\/wp-content\/uploads\/matomo\/matomo.js;s.parentNode.insertBefore(g,s);/script>!-- End Matomo Code -->!-- CookiePro Cookies Consent Notice start for investors.immatics.com -->script srchttps://cookie-cdn.cookiepro.com/scripttemplates/otSDKStub.js  typetext/javascript charsetUTF-8 data-domain-script90980d6f-cf59-47c5-936f-66cc43e9d7f3 >/script>script typetext/javascript>function OptanonWrapper() { }/script>!-- CookiePro Cookies Consent Notice end for investors.immatics.com -->!-- CookiePro Cookies Settings button start -->button idot-sdk-btn classot-sdk-show-settings>Cookie Settings/button>!-- CookiePro Cookies Settings button end -->  /head>  body classbody-sidebars-none nir-node nir-node--type-nir-landing-page nir-node--5806 path-frontpage page-node-type-nir-landing-page>    div idskip>      a classvisually-hidden focusable skip-link href#main-menu>        Skip to main navigation      /a>    /div>          div classdialog-off-canvas-main-canvas data-off-canvas-main-canvas>    header classnavbar affix-top>    div classfull-width>                    div idmain-menu classidp_col-8 nav-area>                div classcol-pad>                                                          div classfield field--name-field-nir-global-block-body field--type-text-long field--label-hidden field__item>a hrefhttps://immatics.com/ classbrand js-target-scroll global-block-content>    img altImmatics Biotechnologies GmbH Logo classimg-responsive center-block enable_sticky_logo logoheader data-entity-typefile data-entity-uuid0e6b2d52-f6b1-443f-bb62-63b42767baad src/system/files-encrypted/nasdaq_kms/inline-images/immatics-white.png>    img altImmatics Biotechnologies GmbH Logo classimg-responsive center-block enable_sticky_logo logostiky data-entity-typefile data-entity-uuidc28c06ab-2bae-40f2-b857-2419fc11aac9 src/system/files-encrypted/nasdaq_kms/inline-images/immatics-black.png>/a>/div>              button typebutton classnavbar-toggle collapsed btn-menu data-togglecollapse data-target#nav-collapse>    span>/span>/button>i classmenutxt>/i>nav rolenavigation aria-labelledbyblock-headermenu-menu idblock-headermenu classblock--system-menu-blockir block--system-menu-blockir--5806 block--header-logo-menu--system-menu-block--ir block--header-logo-menu--system-menu-block--ir--5806 block--3322b75a-a52c-46d1-8149-c9a296585e5d block--3322b75a-a52c-46d1-8149-c9a296585e5d--5806 nav-mobile hidden-md hidden-lg block block-menu navigation block-system-menublock menu--ir styleheight: 555px;>                            h2 classvisually-hidden idblock-headermenu-menu>Header Menu/h2>            div classnavbar-collapse idnav-collapse>                    ul idmenu-main-menu classnav-mobile-list>li  classmenu-item levelOneNoChildren>a target hrefhttps://www.immatics.com>Home/a>/li>li  classmenu-item menu-item-has-children levelOneWithChildren>a target href>Inside Immatics/a>ul classsub-menu>li  class"menu-item levelTwoNoChildren>a target hrefhttps://immatics.com/inside-immatics/about/>About/a>/li>li  class"menu-item levelTwoNoChildren>a target hrefhttps://www.immatics.com/inside-immatics/leadership/>Leadership /a>/li>li  class"menu-item levelTwoNoChildren>a target hrefhttps://www.immatics.com/inside-immatics/bod/>Board of Directors/a>/li>li  class"menu-item levelTwoNoChildren>a target hrefhttps://www.immatics.com/inside-immatics/sab/>Scientific Advisory Board/a>/li>li  class"menu-item levelTwoNoChildren>a target hrefhttps://www.immatics.com/collaborations/>Collaborations/a>/li>li  class"menu-item levelTwoNoChildren>a target hrefhttps://www.immatics.com/locations/>Locations/a>/li>/ul>/li>li  classmenu-item levelOneNoChildren>a target hrefhttps://www.immatics.com/our_pipeline/>Pipeline/a>/li>li  classmenu-item menu-item-has-children levelOneWithChildren>a target href>Unlocking Cancer Immunotherapies/a>ul classsub-menu>li  class"menu-item levelTwoNoChildren>a target hrefhttps://www.immatics.com/t-cells-and-solid-tumors/>T Cells & Solid Tumors /a>/li>li  class"menu-item levelTwoNoChildren>a target hrefhttps://www.immatics.com/true-targets-right-tcrs/>Technologies/a>/li>li  class"menu-item levelTwoNoChildren>a target hrefhttps://www.immatics.com/adoptive-cell-therapies/>Adoptive Cell Therapies/a>/li>li  class"menu-item levelTwoNoChildren>a target hrefhttps://www.immatics.com/next-generation-act/>Next-Generation ACT/a>/li>li  class"menu-item levelTwoNoChildren>a target hrefhttps://www.immatics.com/tcr-bispecifics/>TCR Bispecifics/a>/li>li  class"menu-item levelTwoNoChildren>a target hrefhttps://www.immatics.com/manufacturing/>Manufacturing/a>/li>li  class"menu-item levelTwoNoChildren>a target hrefhttps://www.immatics.com/publications/>Publications/a>/li>/ul>/li>li  classmenu-item menu-item-has-children levelOneWithChildren>a target href>Clinical Trials/a>ul classsub-menu>li  class"menu-item levelTwoNoChildren>a target hrefhttps://immatics.com/overview/>Overview/a>/li>li  class"menu-item levelTwoNoChildren>a target hrefhttps://immatics.com/expanded-access-policy/>Expanded Access Policy/a>/li>/ul>/li>li  classmenu-item menu-item-has-children levelOneWithChildren active-levelOneWithChildren>a target href/investors-media>Investors & Media/a>ul classsub-menu>li  class"menu-item levelTwoNoChildren>a target href/investors-media>Overview/a>/li>li  class"menu-item levelTwoNoChildren>a target href/press-releases>Press Releases/a>/li>li  class"menu-item levelTwoNoChildren>a target href/events-presentations>Events & Presentations/a>/li>li  class"menu-item levelTwoNoChildren>a target href/stock-information>Stock Information/a>/li>li  class"menu-item levelTwoNoChildren>a target href/sec-filings>SEC & Financial Reports/a>/li>li  class"menu-item levelTwoNoChildren>a target href/analyst-coverage>Analyst Coverage/a>/li>li  class"menu-item levelTwoNoChildren>a target href/corporate-governance-compliance>Corporate Governance & Compliance/a>/li>li  class"menu-item levelTwoNoChildren>a target href/faq>FAQ/a>/li>li  class"menu-item levelTwoNoChildren>a target href/downloads>Downloads/a>/li>li  class"menu-item levelTwoNoChildren>a target href/contacts>Contacts/a>/li>/ul>/li>li  classmenu-item menu-item-has-children levelOneWithChildren>a target hrefhttps://www.immatics.com/inside-immatics/working-immatics/>Working @ Immatics/a>ul classsub-menu>li  class"menu-item levelTwoNoChildren>a target hrefhttps://www.immatics.com/inside-immatics/working-immatics/>Working @ Immatics/a>/li>li  class"menu-item levelTwoNoChildren>a target hrefhttps://www.immatics.com/jobs/>Jobs/a>/li>li  class"menu-item levelTwoNoChildren>a target hrefhttps://www.immatics.com/contact-us/>Contact Us/a>/li>/ul>/li>/ul>            /div>/nav>                                                        /div>            /div>                            div classidp_col-4 social-area>                div classcol-pad>                                            div classsome-widget>                            div classmenu-additional-top-menu-container>                                nav rolenavigation aria-labelledbyblock-headerrightlinks-menu idblock-headerrightlinks classblock--system-menu-blockheader---right---links block--system-menu-blockheader---right---links--5826 block--header-right-links--system-menu-block--header---right---links block--header-right-links--system-menu-block--header---right---links--5826 block--b97ba73e-b922-495d-a892-a0b5ae4c9e9e block--b97ba73e-b922-495d-a892-a0b5ae4c9e9e--5826 block block-menu navigation block-system-menublock menu--header---right---links>                            h2 classvisually-hidden idblock-headerrightlinks-menu>Header - Right - Links/h2>                    ul idmenu-additional-top-menu classnav-bottom>li classmenu-item menu-item-type-post_type menu-item-object-page>a target hrefhttps://immatics.com/contact-us/>Contact Us/a>/li>/ul>    /nav>                                                            /div>                        /div>                                                            nav rolenavigation aria-labelledbyblock-sociallinks-menu idblock-sociallinks classblock--system-menu-blocksocial-links block--system-menu-blocksocial-links--5826 block--header-right-social--system-menu-block--social-links block--header-right-social--system-menu-block--social-links--5826 block--4484d8d2-0cca-47d0-ac1c-e635e57cec00 block--4484d8d2-0cca-47d0-ac1c-e635e57cec00--5826 block block-menu navigation block-system-menublock menu--social-links>                            h2 classvisually-hidden idblock-sociallinks-menu>Social Links/h2>                    ul classsocial-list>li>a classfa fa-twitter target_blank hrefhttps://twitter.com/immatics>/a>/li>li>a classfa fa-linkedin target_blank hrefhttps://de.linkedin.com/company/immatics-biotechnologies>/a>/li>/ul>    /nav>                                    /div>            /div>            /div>/header>main classmain main-img stylebackground-image: url(/sites/g/files/knoqqb57156/themes/site/nir_pid3658/client/images/header_investors_f.jpg);>    div classcontainer>        div classopener>            h1>                                                        Investors b>& Media/b>                            /h1>        /div>    /div>/main>div idndq-content classcontent ndq-5806>                                                                                                                                                                              div data-drupal-messages-fallback classhidden>/div>div idblock-nir-pid3658-content classblock--system-main-block block--system-main-block--5806 block--content--system-main-block block--content--system-main-block--5806 block--b01243fc-9de5-4f65-8011-4e61352b9547 block--b01243fc-9de5-4f65-8011-4e61352b9547--5806 block block-system block-system-main-block>            article classnode node--type-nir_landing_page node--view-mode-full clearfix>        h1>              Investors & Media          /h1>      div>    	section classregular home-profile>		div classcontainer>			div classcol-inner>				div classblock-region-slider>                        div classfield field--name-field-nir-lp-block-node field--type-entity-reference field--label-hidden field__item>              div classfield field--name-field-nir-lp-block-body field--type-text-long field--label-hidden field__item>div classcol-md-4>h2 classvc_custom_heading two-line>About span classdifview>Immatics/span>/h2>/div>div classcol-md-8>div classwpb_text_column>p>Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies and TCR Bispecifics as well as our partnerships with global leaders in the pharmaceutical industry. We are committed to delivering the power of T cells and to unlocking new avenues for patients in their fight against cancer. /p>/div>/div>div classclearfix> /div>/div>      /div>        /div>				div classclearfix>/div>			/div>		/div>	/section>	section classregular gray_bg home-stock>		div classcontainer>			div classcol-md-12>				div classblock-region-slidergutter>div data-storage-idnode:5806:full:21041 data-uuidef6147b4-5c48-4bb5-a249-efadc198f426 classblock--market-data-block__stock-quote block--market-data-block__stock-quote--5806 block--slidergutter--market-data-block__stock-quote block--slidergutter--market-data-block__stock-quote--5806 block--ef6147b4-5c48-4bb5-a249-efadc198f426 block--ef6147b4-5c48-4bb5-a249-efadc198f426--5806 block block-nir-market-data-block block-market-data-block__stock-quote>        h2 classvc_custom_heading circle-in-header >            Stock      span classdifview>Quote/span>          /h2>          div classquote-wrap user-toggle-off home-quote>  div classquote-wrapper>                            div classstock-quote data-exchange>      div classhq-left>        div classhq-company>Immatics N.V./div>        div classhq-symbol>/div>      /div>      div classhq-right>        div classhq-price>/div>        div classhq-change >/div>      /div>    /div>    /div>/div>  /div>div classblock--nir-stock-chart block--nir-stock-chart--5806 block--slidergutter--nir-stock-chart block--slidergutter--nir-stock-chart--5806 block--0db1312f-bc5e-49db-9c27-23fe4e6ec3dd block--0db1312f-bc5e-49db-9c27-23fe4e6ec3dd--5806 block block-nir-stock-chart>            iframe srchttps://api.nasdaqomx.wallst.com/advancedchart?displayline&symbolIMTX.O&scalelinear&duration1dy&frequency15min&gridLineb&bgColorffffff&lineColor2daae1&fillcolor2daae1|2daae1&width100%&height440&bdr2&volume1&volColorUpDown68b42d|e30613&lineSizePrimary5 width100% height440 frameborder0 scrollingno allowtransparencytrue classnir-stock-chart>/iframe>  /div>div data-storage-idnode:5806:full:21041 data-uuidb6c99aaa-43a9-4a07-91ce-a861f22d49ee classblock--market-data-block__stock-quote block--market-data-block__stock-quote--5806 block--slidergutter--market-data-block__stock-quote block--slidergutter--market-data-block__stock-quote--5806 block--b6c99aaa-43a9-4a07-91ce-a861f22d49ee block--b6c99aaa-43a9-4a07-91ce-a861f22d49ee--5806 block block-nir-market-data-block block-market-data-block__stock-quote>            div classhome-quote-date>    div classquote-wrapper>                                                                            time>/time>            /div>/div>  /div>div classblock--attribution-block__stock-info-attribution__thomson-reuters block--attribution-block__stock-info-attribution__thomson-reuters--5806 block--slidergutter--attribution-block__stock-info-attribution__thomson-reuters block--slidergutter--attribution-block__stock-info-attribution__thomson-reuters--5806 block--2f58128a-1a49-4441-8f00-f948675b17d4 block--2f58128a-1a49-4441-8f00-f948675b17d4--5806 block block-nir-attribution-block block-attribution-block__stock-info-attribution__thomson-reuters>            p classattribution-legend>  span>    Minimum 15 minutes delayed. Source:  /span>  img src/profiles/nasdaqir/modules/custom/nir_attribution_block/images/lseg_logo.png idlseg-logo alt />/p>  /div>/div>			/div>		/div>		div classclearfix>/div>	/section>	section classregular home-news>		div classcontainer>			div classblock-region-column1>div classblock--home-news block--nir-news__widget block--nir-news__widget--5806 block--column1--nir-news__widget block--column1--nir-news__widget--5806 block--3af540cd-fdfd-4b45-b154-d5c0bb32e60c block--3af540cd-fdfd-4b45-b154-d5c0bb32e60c--5806 block block-nir-news block-nir-news__widget>            div classnir-widget>			div classcol-md-12>			h2 classvc_custom_heading two-line>												Press				span classdifview>& Media/span>			/h2>		/div>		div classnir-widget--content>				div classnir-widget--list>							div classcol-md-12 col-space media>					div classcol-md-4>	div classgray_bg text-center>					h4 classmedia-title>				Immatics Announces Third Quarter 2024 Financial Results, Business Update and First Clinical Data on TCER® IMA402 Targeting PRAME			/h4>				span classvertical-line>/span>					a classbtn href/news-releases/news-release-details/immatics-announces-third-quarter-2024-financial-results-business>read more/a>			/div>/div>div classcol-md-4>	div classgray_bg text-center>					h4 classmedia-title>				Immatics Announces Multiple Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on TCR-T Therapy Candidates Targeting PRAME			/h4>				span classvertical-line>/span>					a classbtn href/news-releases/news-release-details/immatics-announces-multiple-presentations-39th-annual-meeting-0>read more/a>			/div>/div>div classcol-md-4>	div classgray_bg text-center>					h4 classmedia-title>				Immatics Announces Pricing of $150 Million Public Offering			/h4>				span classvertical-line>/span>					a classbtn href/news-releases/news-release-details/immatics-announces-pricing-150-million-public-offering-0>read more/a>			/div>/div>				/div>					/div>					/div>/div>  /div>nav rolenavigation aria-labelledby-menu classblock--system-menu-blockfront-news-view-all block--system-menu-blockfront-news-view-all--5806 block--column1--system-menu-block--front-news-view-all block--column1--system-menu-block--front-news-view-all--5806 block--cba36f79-6168-4214-8da9-15560fe6027d block--cba36f79-6168-4214-8da9-15560fe6027d--5806 block block-menu navigation block-system-menublock menu--front-news-view-all>                            h2 classvisually-hidden id-menu>FRONT >> News > View All/h2>                    div classclearfix>/div>div classcol-md-12 text-center>br />br />a target href/press-releases classbtn>View all/a>/div>    /nav>/div>		/div>	/section>!-- /.brown -->  /div>/article>  /div>div idblock-nir-pid3658-websitenoticeblock classblock--website-notice-block block--website-notice-block--5806 block--content--website-notice-block block--content--website-notice-block--5806 block--e5aa6d79-55f9-4815-9f62-521a39d71dcb block--e5aa6d79-55f9-4815-9f62-521a39d71dcb--5806 block block-nir-website-notices block-website-notice-block>              /div>                                                                              section classregular gray_bg ir-toolkit>            div classcontainer>                div classcol-md-12>                    nav rolenavigation aria-labelledbyblock-toolkit-menu idblock-toolkit classblock--system-menu-blockinvestor-tools block--system-menu-blockinvestor-tools--5826 block--toolkit--system-menu-block--investor-tools block--toolkit--system-menu-block--investor-tools--5826 block--aa1e55e4-8986-4bf4-b7f5-29ed4eceed17 block--aa1e55e4-8986-4bf4-b7f5-29ed4eceed17--5826 block block-menu navigation block-system-menublock menu--investor-tools>                            h2 classvisually-hidden idblock-toolkit-menu>IR Toolkit/h2>                    div idblock-shareholdertools classndq_toolbar>  ul>                        li classlfg-tools-print col-xs-6 col-sm-6 col-md-3>a target href>Print Page/a>/li>              li classlfg-tools-alerts col-xs-6 col-sm-6 col-md-3>a target href/email-alerts>Email Alerts/a>/li>              li classlfg-tools-rss col-xs-6 col-sm-6 col-md-3>a target href/rss-feeds>RSS Feeds/a>/li>              li classlfg-tools-contacts col-xs-6 col-sm-6 col-md-3>a target href/contacts>Contacts/a>/li>              /ul>/div>    /nav>                /div>            /div>        /section>                                    /div>footer idfooter classfooter bg-dark>    div classfull-container blogF>                    div classfooter-widget>                                                      div classfield field--name-field-nir-global-block-body field--type-text-long field--label-hidden field__item>img altImmatics Biotechnologies GmbH Logo classlogo-footer data-entity-typefile data-entity-uuidc28c06ab-2bae-40f2-b857-2419fc11aac9 src/system/files-encrypted/nasdaq_kms/inline-images/immatics-black.png>/div>                                          /div>                            div classfooter-widget>                                                      div classfield field--name-field-nir-global-block-body field--type-text-long field--label-hidden field__item>div classtextwidget>p>strong>Immatics N.V./strong>br>strong>Immatics Biotechnologies GmbH/strong>br>Paul-Ehrlich-Str. 15br>72076 Tuebingenbr>Germany/p>/div>div classtextwidget>p>Phone: +49 7071 5397-0br>Fax: +49 7071 5397-900br>E-Mail: info@immatics.com/p>/div>/div>                                          /div>                            div classfooter-widget>                                                      div classfield field--name-field-nir-global-block-body field--type-text-long field--label-hidden field__item>div classtextwidget>p>strong>Immatics US, Inc./strong>br>13203 Murphy Roadbr>Stafford, Texas 77477br>USA/p>/div>div classtextwidget>p>Business line: +1 346 204-5400br>Fax line: +1 346 204-5931br>E-Mail: info@immatics.com/p>/div>/div>                                          /div>                            div classfooter-widget>                                                      div classfield field--name-field-nir-global-block-body field--type-text-long field--label-hidden field__item>div classtextwidget>    p>strong>Immatics Biotechnologies GmbH/strong>        br>        Machtlfinger Str. 11        br>        81379 Munich        br>        Germany    /p>/div>div classtextwidget>    p>        Phone: +49 (89) 540415-0        br>        Fax: +49 (89) 540415-905        br>        E-Mail: info@immatics.com    /p>/div>/div>                                          /div>                            div classfooter-widget>                                                    div classsome-widget>                        div classmenu-footer-menu-container>                            nav rolenavigation aria-labelledbyblock-footerlinks-menu idblock-footerlinks classblock--system-menu-blockfooter-links block--system-menu-blockfooter-links--5826 block--footer-links--system-menu-block--footer-links block--footer-links--system-menu-block--footer-links--5826 block--799667d4-67d3-4ccf-b139-5489e8a0ea4c block--799667d4-67d3-4ccf-b139-5489e8a0ea4c--5826 block block-menu navigation block-system-menublock menu--footer-links>                            h2 classvisually-hidden idblock-footerlinks-menu>Footer Links/h2>                    ul idmenu-footer-menu classnav-bottom>li classmenu-item>a target hrefhttps://immatics.com/imprint/>Imprint/a>/li>li classmenu-item>a target hrefhttps://immatics.com/privacy-policy-english/>Privacy Policy English/a>/li>li classmenu-item>a target hrefhttps://immatics.com/privacy-policy-german>Privacy Policy German/a>/li>/ul>    /nav>                                                    /div>                    /div>                    div classtextwidget custom-html-widget>a href# classot-sdk-show-settings>Privacy Settings/a>/div>                                                    div classfooter-social>                        nav rolenavigation aria-labelledbyblock-sociallinks-2-menu idblock-sociallinks-2 classblock--system-menu-blocksocial-links block--system-menu-blocksocial-links--5826 block--footer-social--system-menu-block--social-links block--footer-social--system-menu-block--social-links--5826 block--3a80db59-5a27-4605-808d-824fee51ce66 block--3a80db59-5a27-4605-808d-824fee51ce66--5826 block block-menu navigation block-system-menublock menu--social-links>                            h2 classvisually-hidden idblock-sociallinks-2-menu>Social Links/h2>                    ul classsocial-list>li>a classfa fa-twitter target_blank hrefhttps://twitter.com/immatics>/a>/li>li>a classfa fa-linkedin target_blank hrefhttps://de.linkedin.com/company/immatics-biotechnologies>/a>/li>/ul>    /nav>                                            /div>                            /div>            /div>            div classfooter-bottom clearfix>            div classcontainer>                                                      div classfield field--name-field-nir-global-block-body field--type-text-long field--label-hidden field__item>div classcopyrights>© script>document.write((new Date()).getFullYear());/script> Immatics Biotechnologies GmbH/div>/div>                                          /div>        /div>    /footer>div classpopup-bg styledisplay: none;>/div>  /div>              script typetext/javascript>var s_CCSWebHostingAccount  trcgimmatics;/script>        script typeapplication/json data-drupal-selectordrupal-settings-json>{path:{baseUrl:\/,pathPrefix:,currentPath:node\/5806,currentPathIsAdmin:false,isFront:true,currentLanguage:en,themeUrl:sites\/g\/files\/knoqqb57156\/themes\/site\/nir_pid3658},pluralDelimiter:\u0003,suppressDeprecationErrors:true,ajaxPageState:{libraries:eJyVUu1OxSAMfaE5fhiN_30C4wOQAo1rBu1N6bzu7WXsJrobP0MC7enpKbQwqQeGvBrF6vizN0KSgD7DwnEa-FfiSSV1WoCKnUFRuB4hE8kBtINxxkQm6hNYWyFjdR9mpxTQGa0TfMgSZ9erVvMKRvzShJvOBGp_olfftb_hFgT2ilFKQW44Cf-o_SU6bunA6V851dr-tIhdrrZko9KaA-7o9uiJ0u393YOLmZDtZkJIqIeIvKIqpV2sa-_vcFf-XvdxM59tza1BPeOMoZKhZ2nTxX3YV9h4OQeFRG_tj6yyWHUHb6it8VjcNvt399_zEA,theme:nir_pid3658,theme_token:null},ajaxTrustedUrl:,nir_admin_use_chosen:true,nir_admin_use_select2:false,user:{uid:0,permissionsHash:7661dcee295893991b3bd2d9bb262a727adaa95e226024ae0d79dac7ab04e865}}/script>script src/sites/g/files/knoqqb57156/files/js/js_w08SU9eWnHpWMSFsc4UcAkU_ONLN7cIuv_rDHgQn9ps.js?scopefooter&delta0&languageen&themenir_pid3658&includeeJyVkWFKBDEMhS-0Tn-I4n9PIB6gpG1wwrTJ0mbUub2ZVpSRXXAptHmPL5CXMlUfF0ykUn0CtRMyNvdbntiQAnVB7YAPWeLiCgL7ilFKQTafhH2coeoVHhjy1tRXQ_nNB6g34M33WQa7ZqViE4M7ylOzBiwuQBvkXnSGonA7WiqSbYZunindPz48OXnHWinhwYyZkPVuRkg48A8MjRQ9i1K0VV3wpu_3VCHRp8-wyarNHdSV4BfdaV8zcLqpp6ndL6voCNTl2Ln7owf6vJevumVbeO_of2A5RsQfNUGSgBZj5Tj_AzxXSV9ssvMQ>/script>script src/core/assets/vendor/ckeditor5/ckeditor5-dll/ckeditor5-dll.js?v40.2.0>/script>script src/profiles/nasdaqir/modules/custom/nir_ckeditor_datatables/js/build/datatables.js?v1.10.9>/script>script src/sites/g/files/knoqqb57156/files/js/js_vpZZ0JMKklY_tjGlJCKC-rw0mAGRG0DdM7ijYAFeb-Q.js?scopefooter&delta3&languageen&themenir_pid3658&includeeJyVkWFKBDEMhS-0Tn-I4n9PIB6gpG1wwrTJ0mbUub2ZVpSRXXAptHmPL5CXMlUfF0ykUn0CtRMyNvdbntiQAnVB7YAPWeLiCgL7ilFKQTafhH2coeoVHhjy1tRXQ_nNB6g34M33WQa7ZqViE4M7ylOzBiwuQBvkXnSGonA7WiqSbYZunindPz48OXnHWinhwYyZkPVuRkg48A8MjRQ9i1K0VV3wpu_3VCHRp8-wyarNHdSV4BfdaV8zcLqpp6ndL6voCNTl2Ln7owf6vJevumVbeO_of2A5RsQfNUGSgBZj5Tj_AzxXSV9ssvMQ>/script>script srchttps://assets.adobedtm.com/898335afd880/c52ee8aa1e90/launch-5ef258dce664.min.js async integritysha384-9QSqHMB+yiy/V4i+d2Au+ydEWbBz4E9DqsE+oYKOnL+kj4XAZGYZxabd0P3OGHkf>/script>      /body>/html>

View on OTX | View on ThreatMiner

Data with thanks to AlienVault OTX, VirusTotal, Malwr and others. [Sitemap]

Domain > investors.immatics.com

Is this malicious?

Whois

DNS Resolutions

Port 443